P&G Sets Four-Point Turnaround Plan
This article was originally published in The Tan Sheet
Executive Summary
P&G CEO A.G. Lafley’s plan to return the firm to solid fiscal performance focuses on productivity and innovation. While health care product sales grew, the firm reported slight overall growth for its fourth quarter and flat growth for its fiscal 2013.
You may also be interested in...
Lafley Back At P&G Helm As McDonald’s Tenure Ends At Four Years
Procter & Gamble turns to its former leader, previously replaced by Bob McDonald in 2009, after facing investor and analyst pressure to shake up management. Lafley’s return as CEO “provides us with new hope,” one market analyst says.
Women’s Voices For The Earth Will Keep After CIR, Salon Worker Safety In 2024
Women’s Voices for the Earth continues to call attention to cosmetic ingredients’ potential health impacts on users including salon workers, while pushing the Cosmetic Ingredient Review to consider a wider variety of safety information in its assessment work.
Regulatory Acceptance Of Non-Animal Test Methods Holding Back Cosmetics Innovation
“Companies can innovate right now, and they have confidence in these tools, these [non-animal] approaches, and they feel they can put these products on the market safely,” said Erin Hill, CEO and president of the International Collaboration on Cosmetics Safety. “The holdup is that they can’t register these new products, because there’s a lack of confidence in the regulatory community.”